OP0023 GENERATION OF PT101, A HIGHLY SELECTIVE IL-2 MUTEIN FOR TREATMENT OF AUTOIMMUNE DISEASES

白细胞介素2受体 自身免疫 细胞生物学 免疫学 白细胞介素2 免疫系统 生物 T细胞
作者
J. Visweswaraiah,Erik R. Sampson,P. Petaipimol,Alireza Monsef,Katalin Kis‐Tóth,Kevin L. Otipoby,John S. Sundy,Nathan Higginson-Scott,Joanne L. Viney
出处
期刊:Annals of the Rheumatic Diseases [BMJ]
卷期号:80 (Suppl 1): 13.1-13 被引量:10
标识
DOI:10.1136/annrheumdis-2021-eular.2097
摘要

Background: Regulatory T cells (Tregs) play a critical role in immune homeostasis and are dysfunctional in many autoimmune diseases. Interleukin 2 (IL-2) drives the proliferation and function of Tregs. via the heterotrimeric IL-2 receptor (CD25/CD122/CD132). As a result, CD25 loss-of-function in mice is associated with Treg deficiency and widespread autoimmunity. Low dose IL-2 is being evaluated for treatment of autoimmune diseases and has been shown to expand Tregs, however it has a narrow selectivity window before activating conventional T cells and natural killer cells. To enhance IL-2 selectivity and improve its therapeutic utility for activating and expanding Tregs, mutations can be introduced that reduce CD122/CD132 affinity thus creating a dependency on CD25 binding for signaling through CD122/CD132 upon IL-2 facilitated CD25/CD122/CD132 trimer formation. Objectives: To generate a highly selective IL-2 mutein that activates and expands Tregs selectively that can be used for treatment of autoimmune diseases Methods: Using a structure guided approach, we introduced mutations in IL-2 that significantly decreased CD122 binding affinity in addition to other mutations that increased CD25 binding affinity. Finally, we explored additional mutations, format, orientation, and linker lengths to generate the most potent, selective molecule with drug-like manufacturability. These structure activity relationship efforts culminated in the generation of PT101, a mutant IL-2 Fc fusion that is selective in activating and expanding Tregs in vitro and in vivo. Results: PT101 selectively induced STAT5 phosphorylation in human and cynomolgus monkey Tregs in vitro. In humanized NOD-scid IL-2Rg-null (NSG) mice and cynomolgus monkeys, administration of PT101 dose-dependently and selectively expanded Tregs without significant effects on other immune cell types, and without eliciting proinflammatory cytokine production. The Tregs from PT101-dosed humanized mice have increased expression of FOXP3 and CD25, suggesting enhanced function and stability. In a Phase 1a single ascending dose clinical trial, PT101 was well-tolerated and selectively expanded total Tregs, with a mean maximal increase of up to 3.6-fold over baseline in healthy volunteers. There was no evidence of expansion of natural killer cells nor pro-inflammatory conventional T cells at any of the doses studied. Conclusion: PT101 selectively activated and expanded Tregs without significant effects on other immune cell types, and without eliciting proinflammatory cytokine production. These Tregs have enhanced function and stability as seen by increase in expression of FOXP3 and CD25 in these cells. PT101 maintained selectivity in Phase 1 a clinical trial with no evidence of expansion of natural killer cells nor pro-inflammatory conventional T at any dose studied. A Phase 1b/2a clinical trial in patients with ulcerative colitis and a Phase 2 clinical trial in patients with systemic lupus erythematosus are planned to further evaluate PT101. Disclosure of Interests: None declared
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
Tuniverse_发布了新的文献求助10
2秒前
2秒前
chengsi完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
旭东静静发布了新的文献求助10
2秒前
3秒前
3秒前
SciGPT的应助被公孙世往采纳,获得10
3秒前
3秒前
3秒前
3秒前
3秒前
3秒前
有尾的无尾熊完成签到,获得积分10
3秒前
秋风的应助被追寻的钥匙采纳,获得20
4秒前
无极微光的应助被橘子采纳,获得20
4秒前
5秒前
CITY111119发布了新的文献求助10
5秒前
5秒前
6秒前
summer完成签到 ,获得积分10
6秒前
一生所爱发布了新的文献求助10
6秒前
alexwumk发布了新的文献求助10
7秒前
乐观冥幽发布了新的文献求助10
8秒前
呆萌画笔完成签到,获得积分10
8秒前
8秒前
焦哈哈完成签到,获得积分10
9秒前
Aurora发布了新的文献求助10
9秒前
9秒前
10秒前
10秒前
Everglow发布了新的文献求助10
11秒前
Yy杨优秀完成签到 ,获得积分10
11秒前
soory完成签到,获得积分10
12秒前
CipherSage的应助被denty采纳,获得10
13秒前
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181892
求助须知:如何正确求助?哪些是违规求助? 9571628
关于积分的说明 21818984
捐赠科研通 7778258
什么是DOI,文献DOI怎么找? 3433556
关于科研通互助平台的介绍 2557720
邀请新用户注册赠送积分活动 2479621